2024 Interim Award Funding Policy
The Department of Health and Human Services (HHS), including National Institutes of Health (NIH), operates under the Continuing Appropriations Act, 2024 and Other Extensions Act (Public Law 118-015) signed by President Biden on September 30, 2023. This Act (CR) continues government operations through November 17, 2023, at the Fiscal Year (FY) 2023 enacted level, with no reduction.
NIDDK extramural research is organized into 3 programmatic divisions: 1) Diabetes, Endocrinology, and Metabolic Diseases; 2) Digestive Diseases and Nutrition; and 3) Kidney, Urologic, and Hematologic Diseases.
Consistent with NIH practices during the CRs of FYs 2006 - 2023, NIH Institutes and/or Centers may, at their discretion, issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award. Upward adjustments to awarded levels will be considered after FY 2024 appropriations are enacted, but NIH expects institutions to monitor their expenditures carefully during this period. See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-24-007.html for details.
- NIDDK will announce additional details regarding its interim FY 2024 funding policy, including details regarding funding of competing grant applications as information becomes available.